PRTA

Prothena Public Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth↓ 0/10
  • Value↓ 0/10
Prothena Public sales and earnings growth
PRTA Growth
Low
  • Revenue Y/Y↓ -92.83%
  • EPS Y/Y↓ -99.56%
  • FCF Y/Y↓ -8.89%
Prothena Public gross and profit margin trends
PRTA Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -2520.60%
  • ROIC 5Y↑ -766.34%
Prothena Public net debt vs free cash flow
PRTA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Prothena Public stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗